News

Given that individual differences exist regarding the effects of brain injury and gaps persist in the treatment continuum, challenges arise in treating individuals with acquired brain injury. Addressing these challenges can improve patient outcomes.

Remembering a psychiatrist and an activist…

Joint statements from leading psychiatric organizations voice concern about impact on patient care from executive orders and budget cuts.

Review various aspects of cognition in our latest Special Report.

Legislative and legal realities at the state and federal levels are difficult to navigate even for seasoned practitioners, and are beyond the knowledge of most families.

Check out new data from the long-term, open-label KINECT 4 study on Ingrezza capsules for the treatment of tardive dyskinesia.

Learn more about a condition that is often underestimated and mistaken for typical premenstrual symptoms or mood swings: premenstrual dysphoric disorder.

Residents and early career psychiatrists are concerned about the state of psychiatry.

Ketamine or ECT? A new study reveals which works best for severe depression—depending on the patient and setting.

Alzamend announced a late 2025 initiation for the phase 2 clinical study of AL001, a novel lithium-delivery system for the treatment of patients with major depressive disorder.

The REACH Institute announced new pathway to PMHS certification.

Through cinematherapy, Ted Perkins created a program centered on addiction in film that is now used in recovery centers and clinics across the US and Canada.

"I guessed heart failure. The answer was pneumonia."

Can cooperation in space have any implications for better cultural cooperation on earth?

Subscribe to our brand new LinkedIn newsletter!

March 17 through March 23 is National Drug and Alcohol Facts Week 2025.

As we celebrate the anniversary of COVID-19, let’s examine what meaning the pandemic brought to our lives.

In this sponsored video series, review common challenges associated with the treatment of schizophrenia, such as treatment nonadherence and relapse.

Although diagnostic criteria for a depressive episode are the same for unipolar major depression and bipolar depression, these episodes differ in their natural history.

Are these the times that try psychiatrists’ souls?

A new transcranial direct current stimulation device received approval from the FDA for an investigational device exemption, prompting a phase 3 trial.

Digital communication is a powerful tool, but without clear boundaries, it can blur the line between education and clinical care, leading to ethical and professional challenges.

A one-size-fits-all approach does not work—each mother’s experience with postpartum depression is unique.

These words related to psychiatry are officially being banned.

The resource includes the latest research and best practices for addressing the opioid crisis with incarcerated individuals.

Dance/movement therapy has proven to be effective in treating children with trauma, making dance something that can change the way a child develops psychologically.

Psychiatry has a lot to learn from the case of Gabby Petito.

Increased awareness of catatonia and its treatment among health care providers, especially in underresourced areas, is essential for improving patient outcomes.

Today marks 5 years since the World Health Organization declared COVID-19 a pandemic. These are the psychiatric impacts.

A single dose of psilocybin was associated with a significant and sustained reduction in depressive symptoms and possible improvement of PTSD and burnout experienced by clinicians from the front line of the COVID-19 pandemic.